Johnson & Johnson Innovation - JJDC, Inc.'s Net Worth

$0

Who is Johnson & Johnson Innovation - JJDC, Inc.?

Johnson & Johnson Innovation - JJDC, Inc. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CVRx, Inc., Fusion Pharmaceuticals Inc., Provention Bio, Inc., Inspire Medical Systems, Inc., ACHILLION PHARMACEUTICALS INC, Minerva Neurosciences, Inc., Protagonist Therapeutics, Inc, AQUINOX PHARMACEUTICALS, INC, NEVRO CORP, Aldeyra Therapeutics, Inc., GENOCEA BIOSCIENCES, INC., TENGION INC, BARRIER THERAPEUTICS INC, IMMUNICON CORP, CRITICAL THERAPEUTICS INC, UNIVERSAL BIOSENSORS INC, MeiraGTx Holdings plc, and Contineum Therapeutics, Inc..

SEC CIK

Johnson & Johnson Innovation - JJDC, Inc.'s CIK is 0000924020

Past Insider Trading and Trends

2023 was Johnson & Johnson Innovation - JJDC, Inc.'s most active year for disposing of shares, totalling 18 transactions. Johnson & Johnson Innovation - JJDC, Inc.'s most active month to dispose stocks was the month of August. In 2023 Johnson & Johnson Innovation - JJDC, Inc. cashed out on 10,142,912 shares for a total of $0.00, their largest year based on trade value.